文献速递新生儿儿童呼吸

现代新生儿先天性膈疝ECMO治疗的风险变化与矛盾结局

Shifting Risks and Conflicting Outcomes-ECMO for Neonates with Congenital Diaphragmatic Hernia in the Modern Era.
PubMed 文献 · J Pediatr · 2017-01-01

该研究回顾ELSO登记中2500余例接受ECMO的新生儿先天性膈疝(CDH)病例,发现近25年出院存活率下降13.8%,足月儿存活率为48.1%。近10年呼吸性酸中毒患病率翻倍且主要并发症增加,ECMO时长不再为死亡相关危险因素。

要点

  • 近25年CDH新生儿ECMO出院存活率下降13.8%,足月儿存活率48.1%。
  • 近10年呼吸性酸中毒患病率翻倍,主要并发症增加。
  • ECMO上手术结局劣于非ECMO上手术,ECMO时长不再为死亡危险因素。

核心结论

  • 现代新生儿CDH接受ECMO的存活率持续下降。
  • 近10年ECMO安全性改善,但显著呼吸性酸中毒患者数翻倍,增加颅内出血和总体死亡风险。
  • 作者认为对该人群允许性高碳酸血症的风险大于获益。

研究设计与样本

  • 回顾性综述ELSO登记中2500余例接受ECMO的新生儿CDH病例。
  • 采用Cochran-Armitage和多变量回归分析患者人群随时间变化及死亡相关危险因素。

主要发现

  • 近一半(48.1%)足月新生儿存活至出院,过去25年存活率下降13.8%(P < .0001)。
  • 过去10年呼吸性酸中毒患病率翻倍(P < .0001),主要并发症患病率增加(P < .001)。
  • 同期ECMO疗程超过1周的数量增加(P < .001),而多重并发症(>4)患病率下降(P < .0001)。
  • ECMO上手术与较非ECMO上手术更差的结局相关。
  • ECMO时长不再代表死亡相关危险因素。

关键数值与推荐

  • 足月新生儿CDH接受ECMO的出院存活率为48.1%。
  • 过去25年存活率下降13.8%(P < .0001)。
  • 过去10年呼吸性酸中毒患病率翻倍(P < .0001),主要并发症增加(P < .001)。
  • 过去10年ECMO疗程超过1周的数量增加(P < .001),多重并发症(>4)患病率下降(P < .0001)。

临床怎么用

  • 对CDH新生儿ECMO治疗需关注呼吸性酸中毒风险,其增加颅内出血和死亡风险。
  • ECMO上手术结局较差,临床决策需权衡手术时机。
  • ECMO时长不再作为死亡风险因素,需综合评估其他风险指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To update previously described trends for neonates with congenital diaphragmatic hernia (CDH) receiving ECMO with changes in recommendations for care, and to determine how recent advancements in respiratory care have affected this patient population. STUDY DESIGN: This study is a retrospective review of more than 2500 neonates with CDH who received ECMO listed in the Extracorporeal Life Support Organization (ELSO) registry. Cochran-Armitage and multivariate regression analyses were used to analyze changes in the patient population over time and in mortality-related risk factors. RESULTS: Almost one-half (48.1%) of the term neonates survived to discharge, representing a 13.8% decline in survival over the past 25 years (P < .0001). Over the past 10 years, the prevalence of respiratory acidosis more than doubled (P < .0001) and the prevalence of major complications increased (P < .001). During the same period, the number of ECMO courses longer than 1 week increased (P < .001), whereas the prevalence of multiple complications (>4) decreased (P < .0001). Surgeries performed on ECMO were associated with worse outcomes than those performed off ECMO. ECMO duration no longer represents a mortality-related risk factor. CONCLUSIONS: Survival rates for neonates with CDH receiving ECMO have continued to drop in the modern era. Although the safety of ECMO has improved over the last decade, the number of patients experiencing significant respiratory acidosis has more than doubled-increasing the risk of intracranial hemorrhage and overall mortality. The evidence for permissive hypercapnia remains mixed; nonetheless, we believe that the risks outweigh the rewards in this patient population.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Turek JW, Nellis JR, Sherwood BG, et al. Shifting Risks and Conflicting Outcomes-ECMO for Neonates with Congenital Diaphragmatic Hernia in the Modern Era. J Pediatr. 2017. PMID: 29144241. doi:10.1016/j.jpeds.2017.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。